Poster zum Thema "Spasticity"

Zurück
  • P-370
Does the intramuscular injection of Botulinum Neurotoxin-A induce muscular weakness in adult-onset neurological patients with focal spasticity? A systematic review
  • Professor Gavin Williams (Richmond / AU; Melbourne / AU)
  • P-411
Living with spasticity during the COVID-19 pandemic. A qualitative study of patient, carer and physician experiences
  • P-412
A 5-year retrospective cohort of individuals receiving botulinum toxin type a for post stroke spasticity
  • P-413
Predictors of spasticity 3-6 months post stroke: a 5-year retrospective cohort study
  • P-414
Intervention based on FES and splinting for treating the non-neural hyper-resistance of the hand joints in a person with incomplete spinal cord injury
  • P-415
Neuromuscular electrical stimulation as a spasticity reduction tool before functional hand and gait training in two persons with stroke
  • P-416
To pump or not to pump? An evaluation using temporary intrathecal device coupled with goal attainment scaling to assess the indication and predict outcome of intrathecal baclofen therapy
  • P-417
Diagnostic nerve blocks. A retrospective analysis of 2020-2022
  • P-418
Effectiveness of abobotulinumtoxinA in adults with lower limb spasticity: top line results from the AboLiSh observational study
  • P-419
Effects of muscle shortening maneuver on a child with cerebral palsy: a case report
  • P-420
A retrospective cohort analysis of cryoneurolysis for upper extremity spasticity in patients with cerebral palsy
  • P-421
Evaluation of the safety and effectiveness of intramuscular motor blocks in physical and rehabilitation medicine
  • P-422
Moving casting into clinical practice: a knowledge translation proposal
  • P-423
Repeated Botulinum toxin A injections for a period of two years in stroke patients – effect on muscle stiffness, goal attainment and functional outcome
  • P-424
Reduction of pain in spasticity patients naïve and non-naïve to OnabotulinumtoxinA treatment: results from the aspire study
  • P-425
Initial validation of structured patient self-reports on three treatment-relevant symptoms of upper limb spastic movement disorders (UL-SMD) after stroke
  • P-426
Cryoneurolysis and quadriplegia: a case report on pain and spasticity management
  • P-427
Madglove: creating an accessible home-rehabilitation glove to increase independence in people with spasticity
  • P-428
Long-term effect of the selective tibial neurotomy for the treatment of the spastic foot evaluated by a patient goal-centered approach
  • P-429
An innovative approach to treating spastic and contractures shoulder: combining percutaneous cryoneurolysis and percutaneous needle tenotomy. A case series
  • P-430
Spasticity interventions in cerebral palsy for people with and without intellectual disabilities – a comparative analysis
  • P-431
Multisite treatment in upper and lower limb with percutaneous cryoneurolysis for hemiplegia in long standing refractory post stroke spasticity
  • P-432
Reduction of lower limbs spasticity after suppression of intravesical noxious stimulus evidenced by gait analysis
  • P-433
Ultrasound image guided injection of botulinum toxin for the management of spasticity: a Delphi study to develop a international scope of practice, competency, and a governance framework
    • v1.20.0
    • © Conventus Congressmanagement & Marketing GmbH